Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Das SK, Bhutia SK, Kegelman TP, Peachy L, Oyesanya RA, Dasgupta S, Sokhi UK, Azab B, Dash R, Quinn BA, Kim K, Barral PM, Su ZZ, Boukerche H, Sarkar D, Fisher PB. Das SK, et al. Among authors: dasgupta s. Front Biosci (Landmark Ed). 2012 Jan 1;17(1):1-15. doi: 10.2741/3911. Front Biosci (Landmark Ed). 2012. PMID: 22201728 Free article. Review.
MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.
Das SK, Bhutia SK, Azab B, Kegelman TP, Peachy L, Santhekadur PK, Dasgupta S, Dash R, Dent P, Grant S, Emdad L, Pellecchia M, Sarkar D, Fisher PB. Das SK, et al. Among authors: dasgupta s. Cancer Res. 2013 Jan 15;73(2):844-54. doi: 10.1158/0008-5472.CAN-12-1681. Epub 2012 Dec 10. Cancer Res. 2013. PMID: 23233738 Free PMC article.
MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME, Emdad L, Dasgupta S, Baldwin AS, Bruce JN, Dent P, Pellecchia M, Sarkar D, Fisher PB. Kegelman TP, et al. Among authors: dasgupta s. Neuro Oncol. 2014 Jan;16(1):50-61. doi: 10.1093/neuonc/not157. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24305713 Free PMC article.
MDA-7/IL-24: multifunctional cancer killing cytokine.
Menezes ME, Bhatia S, Bhoopathi P, Das SK, Emdad L, Dasgupta S, Dent P, Wang XY, Sarkar D, Fisher PB. Menezes ME, et al. Among authors: dasgupta s. Adv Exp Med Biol. 2014;818:127-53. doi: 10.1007/978-1-4471-6458-6_6. Adv Exp Med Biol. 2014. PMID: 25001534 Free PMC article. Review.
Targeting Mcl-1 for the therapy of cancer.
Quinn BA, Dash R, Azab B, Sarkar S, Das SK, Kumar S, Oyesanya RA, Dasgupta S, Dent P, Grant S, Rahmani M, Curiel DT, Dmitriev I, Hedvat M, Wei J, Wu B, Stebbins JL, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Quinn BA, et al. Among authors: dasgupta s. Expert Opin Investig Drugs. 2011 Oct;20(10):1397-411. doi: 10.1517/13543784.2011.609167. Epub 2011 Aug 19. Expert Opin Investig Drugs. 2011. PMID: 21851287 Free PMC article. Review.
Targeting the Bcl-2 family for cancer therapy.
Thomas S, Quinn BA, Das SK, Dash R, Emdad L, Dasgupta S, Wang XY, Dent P, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Thomas S, et al. Among authors: dasgupta s. Expert Opin Ther Targets. 2013 Jan;17(1):61-75. doi: 10.1517/14728222.2013.733001. Epub 2012 Nov 22. Expert Opin Ther Targets. 2013. PMID: 23173842 Free PMC article. Review.
Innovative approaches for enhancing cancer gene therapy.
Bhatia S, Menezes ME, Das SK, Emdad L, Dasgupta S, Wang XY, Sarkar D, Fisher PB. Bhatia S, et al. Among authors: dasgupta s. Discov Med. 2013 May;15(84):309-17. Discov Med. 2013. PMID: 23725604 Free article. Review.
1,866 results